Asymmetric dimethylarginine in adult falciparum malaria: Relationships with disease severity, antimalarial treatment, hemolysis, and inflammation

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Barber, Bridget E ^a   William, Timothy ^a,b   Grigg, Matthew J ^a   Parameswaran, Uma ^a   Piera, Kim A ^a   Yeo, Tsin W ^a,c,d   Anstey, Nicholas M ^a,e  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b Jesselton Medical Centre   (Malaysia)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

ADMA; Arginine; Malaria; Nitric oxide; Plasmodium falciparum

Indexed keywords

EID: 85000384178     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw027     Document Type: Article

References (41)

1. Dondorp A, Nosten F, Stepniewska K, et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366:717-25.
2. Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 2013; 19:156-67.
3. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-8.
4. Serirom S, Raharjo WH, Chotivanich K, et al. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol 2003; 162:1651-60.
5. Vaughn MW, Kuo L, Liao JC. Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol 1998; 274:H1705-14.
6. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204:2693-704.
7. Yeo TW, Lampah DA, Kenangalem E, et al. Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria. J Infect Dis 2014; 210: 1627-32.
8. Yeo TW, Lampah DA, Gitawati R, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A 2008; 105:17097-102.
9. Hanson J, Lee SJ, Hossain MA, et al. Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: an observational study. BMC Med 2015; 13:122.
10. Cardounel AJ, Cui H, Samouilov A, et al. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 2007; 282:879-87.
11. Caplin B, Leiper J. Endogenous nitric oxide synthase inhibitors in the biology of disease markers, mediators, and regulators? Arterioscler Thromb Vasc Biol 2012; 32:1343-53.
12. Davis JS, Darcy CJ, Yeo TW, et al. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One 2011; 6:e17260.
13. Yeo T, Lampah D, Tjitra E, et al. Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog 2010; 6:e1000868.
14. Weinberg JB, Yeo TW, Mukemba JP, et al. Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria. J Infect Dis 2014; 210:913-22.
15. Chertow JH, Alkaitis MS, Nardone G, et al. Plasmodium infection is associated with impaired hepatic dimethylarginine dimethylaminohydrolase activity and disruption of nitric oxide synthase inhibitor/substrate homeostasis. PLoS Pathog 2015; 11:e1005119.
16. Wang J, Sim A, Wang X, Wilcken D. L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells. Cell Mol Life Sci 2006; 63:2838-46.
17. Strobel J, Mieth M, Endreß B, et al. Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1). J Mol Cell Cardiol 2012; 53:392-400.
18. Kayacelebi AA, Langen J, Weigt-Usinger K, et al. Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans. Amino Acids 2015; 47:1893-908.
19. Iapichino G, Umbrello M, Albicini M, et al. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Minerva Anestesiol 2010; 76: 325-33.
20. Nijveldt R, Teerlink T, Van Der Hoven Ba, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22:23-30.
21. Barber BE, William T, Grigg MJ, et al. A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis 2013; 56:383-97.
22. Padley D, Moody A, Chiodini P, Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol 2003; 97:131-7.
23. Imwong M, Tanomsing N, Pukrittayakamee S, et al. Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect P. knowlesi. J Clin Microbiol 2009; 47:4173-5.
24. Jones CE, Darcy CJ, Woodberry T, et al. HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878:8-12.
25. Nohria A, Gerhard-Herman M, Creager M, et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101:545-8.
26. Žunic G, Tomic A, Spasic S. Unilateral nephrectomy causes an early abrupt decrease in plasma arginine and simultaneous reduction in glomerular filtration rate in living kidney donors. Clin Biochem 2013; 46:1394-8.
27. Blackwell S, O'Reilly DS, Reid D, Talwar D. Plasma dimethylarginines during the acute inflammatory response. Eur J Clin Invest 2011; 41:635-41.
28. Nijveldt RJ, Siroen MP, Teerlink T, et al. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 2004; 24:510-8.
29. Kielstein JT, Veldink H, Martens-Lobenhoffer J, et al. Unilateral nephrectomy causes an abrupt increase in inflammatory mediators and a simultaneous decrease in plasma ADMA: a study in living kidney donors. Am J Physiol Renal Physiol 2011; 301:F1042-6.
30. Ueda S, Kato S, Matsuoka H, et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine role of dimethylarginine dimethylaminohydrolase. Circ Res 2003; 92:226-33.
31. Zoccali C, Maas R, Cutrupi S, et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007; 22: 801-6.
32. Strobel J, Müller F, Zolk O, et al. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1). Amino Acids 2013; 45:989-1002.
33. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 2009; 60:448-60.
34. Hattori Y, Kasai K, Gross S. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 1999; 276: H2020-8.
35. Li J, Wilson A, Gao X, et al. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J Pharmacol Exp Ther 2009; 331:234-43.
36. Closs EI, Ostad MA, Simon A, et al. Impairment of the extrusion transporter for asymmetric dimethyl-l-arginine: A novel mechanism underlying vasospastic angina. Biochem Biophys Res Commun 2012; 423:218-23.
37. Guo L, Tian S, Chen Y, et al. CAT-1 as a novel CAMstabilizes endothelial integrity and mediates the protective actions of L-Arg via a NO-independent mechanism. J Mol Cell Cardiol 2015; 87:180-91.
38. Davids M, van Hell AJ, Visser M, et al. Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am J Physiol Heart Circ Physiol 2012; 302:H1762-70.
39. Ferrigno A, Di Pasqua LG, Berardo C, et al. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury. World J Gastroenterol 2015; 21:5131-7.
40. Ferrigno A, Rizzo V, Bianchi A, et al. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. Biomed Res Int 2014; .
41. Yeo T, Lampah D, Gitawati R, et al. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J Infect Dis 2008; 198:602-8.